Does SILO Pharma Inc (NASDAQ: SILO) Still Look Attractive After A -1.45% Selloff Last Week?

During the last session, SILO Pharma Inc (NASDAQ:SILO)’s traded shares were 1.12 million, with the beta value of the company hitting 1.55. At the end of the trading day, the stock’s price was $1.36, reflecting an intraday gain of 1.49% or $0.02. The 52-week high for the SILO share is $4.50, that puts it down -230.88 from that peak though still a striking 43.38% gain since the share price plummeted to a 52-week low of $0.77. The company’s market capitalization is $6.10M, and the average intraday trading volume over the past 10 days was 0.2 million shares, and the average trade volume was 3.13 million shares over the past three months.

SILO Pharma Inc (NASDAQ:SILO) trade information

SILO Pharma Inc (SILO) registered a 1.49% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.49% in intraday trading to $1.36, hitting a weekly high. The stock’s 5-day price performance is -1.45%, and it has moved by -2.16% in 30 days. Based on these gigs, the overall price performance for the year is -26.88%. The short interest in SILO Pharma Inc (NASDAQ:SILO) is 0.18 million shares and it means that shorts have 1.44 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -4.01%.

SILO Dividends

SILO Pharma Inc is due to release its next quarterly earnings on 2024-Mar-24. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

SILO Pharma Inc (NASDAQ:SILO)’s Major holders

SILO Pharma Inc insiders own 4.30% of total outstanding shares while institutional holders control 4.09%, with the float percentage being 4.28%.

Also, the Mutual Funds coming in first place with the largest holdings of SILO Pharma Inc (SILO) shares are AdvisorShares Psychedelics ETF and Fidelity Extended Market Index Fund . Data provided on Feb 28, 2025 indicates that AdvisorShares Psychedelics ETF owns about 71.88 shares. This amounts to just over 0.07 percent of the company’s overall shares, with a $97759.0 market value. The same data shows that the other fund manager holds slightly less at 24.13, or about 0.02% of the stock, which is worth about $32811.0.